Literature DB >> 22021427

Comparative toxicity of polyglutamine, polyalanine and polyleucine tracts in Drosophila models of expanded repeat disease.

Clare L van Eyk1, Catherine J McLeod, Louise V O'Keefe, Robert I Richards.   

Abstract

Homopolymeric amino acid repeat sequences in proteins are of particular interest due to the discovery that expanded copy numbers of these repeats are the molecular basis for a growing list of human genetic diseases. Repeat copy numbers above a typical normal range of polyglutamine repeats have been found to be the principal pathogenic agents in a number of these diseases, including Huntington's disease. There is emerging evidence that expansions of amino acids encoded by other reading frames of CAG/CUG repeats, including polyalanine and polyleucine, could contribute to toxicity in the 'polyglutamine' diseases. We have therefore used the Drosophila model system to investigate effects of ectopic expression of polyglutamine, polyleucine and polyalanine repeats in vivo to assess their relative toxicities and the common and distinct characteristics of the pathogenesis that they cause. We find that these homopolymeric sequences all exhibit toxicity and are able to form aggregates in Drosophila, although there are marked differences in the degree of toxicity dependent upon the tissue in which they are expressed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22021427     DOI: 10.1093/hmg/ddr487

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  13 in total

1.  Diverse single-amino-acid repeat profiles in the genus Cryptosporidium.

Authors:  Giovanni Widmer
Journal:  Parasitology       Date:  2018-02-12       Impact factor: 3.234

Review 2.  Tandem repeats mediating genetic plasticity in health and disease.

Authors:  Anthony J Hannan
Journal:  Nat Rev Genet       Date:  2018-02-05       Impact factor: 53.242

3.  Distinct roles for Toll and autophagy pathways in double-stranded RNA toxicity in a Drosophila model of expanded repeat neurodegenerative diseases.

Authors:  Saumya E Samaraweera; Louise V O'Keefe; Gareth R Price; Deon J Venter; Robert I Richards
Journal:  Hum Mol Genet       Date:  2013-03-21       Impact factor: 6.150

4.  A Novel Caenorhabditis Elegans Proteinopathy Model Shows Changes in mRNA Translational Frameshifting During Aging.

Authors:  Frauke Adamla; Jarod Rollins; Matthew Newsom; Santina Snow; Markus Schosserer; Clemens Heissenberger; Jordan Horrocks; Aric N Rogers; Zoya Ignatova
Journal:  Cell Physiol Biochem       Date:  2019

5.  Ubiquitous expression of CUG or CAG trinucleotide repeat RNA causes common morphological defects in a Drosophila model of RNA-mediated pathology.

Authors:  Kynan T Lawlor; Louise V O'Keefe; Saumya E Samaraweera; Clare L van Eyk; Robert I Richards
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

6.  Repeat-associated non-AUG translation from antisense CCG repeats in fragile X tremor/ataxia syndrome.

Authors:  Amy Krans; Michael G Kearse; Peter K Todd
Journal:  Ann Neurol       Date:  2016-11-26       Impact factor: 11.274

Review 7.  RNA-mediated pathogenic mechanisms in polyglutamine diseases and amyotrophic lateral sclerosis.

Authors:  Ho Yin Edwin Chan
Journal:  Front Cell Neurosci       Date:  2014-12-19       Impact factor: 5.505

8.  The role of RNA metabolism in neurological diseases.

Authors:  A M Alaqeel; H Abou Al-Shaar; R K Shariff; A Albakr
Journal:  Balkan J Med Genet       Date:  2016-07-09       Impact factor: 0.519

9.  RNA pathogenesis via Toll-like receptor-activated inflammation in expanded repeat neurodegenerative diseases.

Authors:  Robert I Richards; Saumya E Samaraweera; Clare L van Eyk; Louise V O'Keefe; Catherine M Suter
Journal:  Front Mol Neurosci       Date:  2013-09-05       Impact factor: 5.639

10.  Non-random distribution of homo-repeats: links with biological functions and human diseases.

Authors:  Michail Yu Lobanov; Petr Klus; Igor V Sokolovsky; Gian Gaetano Tartaglia; Oxana V Galzitskaya
Journal:  Sci Rep       Date:  2016-06-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.